The Role of Estrogens in Control of Energy Balance and Glucose Homeostasis
Tóm tắt
Từ khóa
Tài liệu tham khảo
Keating, 1999, Use of hormone replacement therapy by postmenopausal women in the United States, Ann Intern Med, 130, 545, 10.7326/0003-4819-130-7-199904060-00002
Ziel, 1975, Increased risk of endometrial carcinoma among users of conjugated estrogens, N Engl J Med, 293, 1167, 10.1056/NEJM197512042932303
Smith, 1975, Association of exogenous estrogen and endometrial carcinoma, N Engl J Med, 293, 1164, 10.1056/NEJM197512042932302
Rossouw, 2002, Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results from the Women's Health Initiative randomized controlled trial, JAMA, 288, 321, 10.1001/jama.288.3.321
Santen, 2010, Postmenopausal hormone therapy: an Endocrine Society scientific statement, J Clin Endocrinol Metab, 95, s1, 10.1210/jc.2009-2509
Carr, 2003, The emergence of the metabolic syndrome with menopause, J Clin Endocrinol Metab, 88, 2404, 10.1210/jc.2003-030242
Mauvais-Jarvis, 2011, Estrogen and androgen receptors: regulators of fuel homeostasis and emerging targets for diabetes and obesity, Trends Endocrinol Metab, 22, 24, 10.1016/j.tem.2010.10.002
Simpson, 2005, Estrogen—the good, the bad, and the unexpected, Endocr Rev, 26, 322, 10.1210/er.2004-0020
Mauvais-Jarvis, 2012, Estrogen sulfotransferase: intracrinology meets metabolic diseases, Diabetes, 61, 1353, 10.2337/db12-0357
O'Malley, 1971, Mechanisms of action of steroid hormones, N Engl J Med, 284, 370, 10.1056/NEJM197102182840710
Safe, 2008, Non-classical genomic estrogen receptor (ER)/specificity protein and ER/activating protein-1 signaling pathways, J Mol Endocrinol, 41, 263, 10.1677/JME-08-0103
Paech, 1997, Differential ligand activation of estrogen receptors ERα and ERβ at AP1 sites, Science, 277, 1508, 10.1126/science.277.5331.1508
Powell, 2008, Intermolecular interactions identify ligand-selective activity of estrogen receptor α/β dimers, Proc Natl Acad Sci USA, 105, 19012, 10.1073/pnas.0807274105
Charn, 2010, Genome-wide dynamics of chromatin binding of estrogen receptors α and β: mutual restriction and competitive site selection, Mol Endocrinol, 24, 47, 10.1210/me.2009-0252
Shang, 2000, Cofactor dynamics and sufficiency in estrogen receptor-regulated transcription, Cell, 103, 843, 10.1016/S0092-8674(00)00188-4
Liu, 2010, Minireview: estrogenic protection of β-cell failure in metabolic diseases, Endocrinology, 151, 859, 10.1210/en.2009-1107
Hammes, 2007, Extranuclear steroid receptors: nature and actions, Endocr Rev, 28, 726, 10.1210/er.2007-0022
Tiano, 2012, Importance of oestrogen receptors to preserve functional β-cell mass in diabetes, Nat Rev Endocrinol, 8, 342, 10.1038/nrendo.2011.242
van Londen, 2011, The impact of an aromatase inhibitor on body composition and gonadal hormone levels in women with breast cancer, Breast Cancer Res Treat, 125, 441, 10.1007/s10549-010-1223-2
Madak-Erdogan, 2011, Genomic collaboration of estrogen receptor α and extracellular signal-regulated kinase 2 in regulating gene and proliferation programs, Mol Cell Biol, 31, 226, 10.1128/MCB.00821-10
Kang, 2010, Involvement of estrogen receptor variant ER-α36, not GPR30, in nongenomic estrogen signaling, Mol Endocrinol, 24, 709, 10.1210/me.2009-0317
Laudet, 1997, Evolution of the nuclear receptor superfamily: early diversification from an ancestral orphan receptor, J Mol Endocrinol, 19, 207, 10.1677/jme.0.0190207
Thornton, 2003, Resurrecting the ancestral steroid receptor: ancient origin of estrogen signaling, Science, 301, 1714, 10.1126/science.1086185
Eick, 2011, Evolution of steroid receptors from an estrogen-sensitive ancestral receptor, Mol Cell Endocrinol, 334, 31, 10.1016/j.mce.2010.09.003
Bridgham, 2006, Evolution of hormone-receptor complexity by molecular exploitation, Science, 312, 97, 10.1126/science.1123348
Carroll, 2008, Evolution of hormone signaling in elasmobranchs by exploitation of promiscuous receptors, Mol Biol Evol, 25, 2643, 10.1093/molbev/msn204
Markov, 2009, Independent elaboration of steroid hormone signaling pathways in metazoans, Proc Natl Acad Sci USA, 106, 11913, 10.1073/pnas.0812138106
Blaustein, 1976, Ovarian influences on the meal patterns of female rats, Physiol Behav, 17, 201, 10.1016/0031-9384(76)90064-0
Drewett, 1973, Sexual behaviour and sexual motivation in the female rat, Nature, 242, 476, 10.1038/242476a0
Wallen, 2001, Sex hormones and the selective estrogen receptor modulator tamoxifen modulate weekly body weights and food intakes in adolescent and adult rats, J Nutr, 131, 2351, 10.1093/jn/131.9.2351
Geary, 2001, Deficits in E2-dependent control of feeding, weight gain, and cholecystokinin satiation in ER-α null mice, Endocrinology, 142, 4751, 10.1210/endo.142.11.8504
Gao, 2007, Anorectic estrogen mimics leptin's effect on the rewiring of melanocortin cells and Stat3 signaling in obese animals, Nat Med, 13, 89, 10.1038/nm1525
Ding, 2009, Sex hormone-binding globulin and risk of type 2 diabetes in women and men, N Engl J Med, 361, 1152, 10.1056/NEJMoa0804381
Jones, 2000, Aromatase-deficient (ArKO) mice have a phenotype of increased adiposity, Proc Natl Acad Sci USA, 97, 12735, 10.1073/pnas.97.23.12735
Heine, 2000, Increased adipose tissue in male and female estrogen receptor-α knockout mice, Proc Natl Acad Sci USA, 97, 12729, 10.1073/pnas.97.23.12729
Ribas, 2010, Impaired oxidative metabolism and inflammation are associated with insulin resistance in ERα deficient mice, Am J Physiol Endocrinol Metab, 298, E304, 10.1152/ajpendo.00504.2009
Rogers, 2009, Reduced energy expenditure and increased inflammation are early events in the development of ovariectomy-induced obesity, Endocrinology, 150, 2161, 10.1210/en.2008-1405
Smith, 2000, The controls of eating: a shift from nutritional homeostasis to behavioral neuroscience, Nutrition, 16, 814, 10.1016/S0899-9007(00)00457-3
Louis-Sylvestre, 1980, Neuroendocrinology of hyperphagias and obesities, Reprod Nutr Dev, 20, 1545, 10.1051/rnd:19800901
Danguir, 1980, Cortical activity and sleep in the rat lateral hypothalamic syndrome, Brain Res, 185, 305, 10.1016/0006-8993(80)91070-7
Milam, 1980, Effect of lateral hypothalamic lesions on regulation of body weight and adiposity in rats, Am J Physiol, 239, R337
Simerly, 1990, Distribution of androgen and estrogen receptor mRNA-containing cells in the rat brain: an in situ hybridization study, J Comp Neurol, 294, 76, 10.1002/cne.902940107
Simonian, 1997, Differential expression of estrogen receptor α and β immunoreactivity by oxytocin neurons of rat paraventricular nucleus, J Neuroendocrinol, 9, 803, 10.1046/j.1365-2826.1997.00659.x
Voisin, 1997, Identification of estrogen receptor-containing neurons projecting to the rat supraoptic nucleus, Neuroscience, 78, 215, 10.1016/S0306-4522(96)00551-9
Osterlund, 1998, Differential distribution and regulation of estrogen receptor-α and -β mRNA within the female rat brain, Brain Res Mol Brain Res, 54, 175, 10.1016/S0169-328X(97)00351-3
Wilkinson, 2002, Identification and characterization of a functionally distinct form of human estrogen receptor β, Endocrinology, 143, 1558, 10.1210/endo.143.4.8829
Shima, 2003, Distribution of estrogen receptor β mRNA-containing cells in ovariectomized and estrogen-treated female rat brain, Anat Sci Int, 78, 85, 10.1046/j.0022-7722.2003.00042.x
Merchenthaler, 2004, Distribution of estrogen receptor α and β in the mouse central nervous system: in vivo autoradiographic and immunocytochemical analyses, J Comp Neurol, 473, 270, 10.1002/cne.20128
Ohlsson, 2000, Obesity and disturbed lipoprotein profile in estrogen receptor-α- deficient male mice, Biochem Biophys Res Commun, 278, 640, 10.1006/bbrc.2000.3827
Roesch, 2006, Effects of selective estrogen receptor agonists on food intake and body weight gain in rats, Physiol Behav, 87, 39, 10.1016/j.physbeh.2005.08.035
Santollo, 2007, Acute activation of ER α decreases food intake, meal size, and body weight in ovariectomized rats, Am J Physiol Regul Integr Comp Physiol, 293, R2194, 10.1152/ajpregu.00385.2007
Liang, 2002, Estrogen receptor β is involved in the anorectic action of estrogen, Int J Obes Relat Metab Disord, 26, 1103, 10.1038/sj.ijo.0802054
Yepuru, 2010, Estrogen receptor-β selective ligands alleviate high-fat diet- and ovariectomy-induced obesity in mice, J Biol Chem, 285, 31292, 10.1074/jbc.M110.147850
Langer, 2010, A critical review of fundamental controversies in the field of GPR30 research, Steroids, 75, 603, 10.1016/j.steroids.2009.12.006
Dhillon, 2011, Estrogen inhibits NPY secretion through membrane-associated estrogen receptor (ER)-α in clonal, immortalized hypothalamic neurons, Int J Obes (Lond), 35, 198, 10.1038/ijo.2010.124
Qiu, 2006, A G-protein-coupled estrogen receptor is involved in hypothalamic control of energy homeostasis, J Neurosci, 26, 5649, 10.1523/JNEUROSCI.0327-06.2006
Roepke, 2010, Contribution of a membrane estrogen receptor to the estrogenic regulation of body temperature and energy homeostasis, Endocrinology, 151, 4926, 10.1210/en.2010-0573
Xu, 2011, Distinct hypothalamic neurons mediate estrogenic effects on energy homeostasis and reproduction, Cell Metab, 14, 453, 10.1016/j.cmet.2011.08.009
Elmquist, 1998, Unraveling the central nervous system pathways underlying responses to leptin, Nat Neurosci, 1, 445, 10.1038/2164
Elias, 1999, Leptin differentially regulates NPY and POMC neurons projecting to the lateral hypothalamic area, Neuron, 23, 775, 10.1016/S0896-6273(01)80035-0
Elmquist, 1999, From lesions to leptin: hypothalamic control of food intake and body weight, Neuron, 22, 221, 10.1016/S0896-6273(00)81084-3
Elias, 2000, Chemical characterization of leptin-activated neurons in the rat brain, J Comp Neurol, 423, 261, 10.1002/1096-9861(20000724)423:2<261::AID-CNE6>3.0.CO;2-6
Wise, 1990, Diurnal pattern of proopiomelanocortin gene expression in the arcuate nucleus of proestrous, ovariectomized, and steroid-treated rats: a possible role in cyclic luteinizing hormone secretion, Mol Endocrinol, 4, 886, 10.1210/mend-4-6-886
Bohler, 1991, Changes in proopiomelanocortin messenger ribonucleic acid levels in the rostral periarcuate region of the female rat during the estrous cycle, Endocrinology, 128, 1265, 10.1210/endo-128-3-1265
Korner, 1999, Regulation of hypothalamic proopiomelanocortin by leptin in lean and obese rats, Neuroendocrinology, 70, 377, 10.1159/000054499
Slamberová, 2004, Expression of proopiomelanocortin and proenkephalin mRNA in sexually dimorphic brain regions are altered in adult male and female rats treated prenatally with morphine, J Pept Res, 63, 399, 10.1111/j.1399-3011.2004.00134.x
Hirosawa, 2008, Ablation of estrogen receptor α (ERα) prevents upregulation of POMC by leptin and insulin, Biochem Biophys Res Commun, 371, 320, 10.1016/j.bbrc.2008.04.073
Polidori, 2002, Estradiol treatment fails to affect the feeding responses to melanocortin-3/4 receptor agonism or antagonism in ovariectomized rats, Peptides, 23, 1697, 10.1016/S0196-9781(02)00112-2
Malyala, 2008, PI3K signaling effects in hypothalamic neurons mediated by estrogen, J Comp Neurol, 506, 895, 10.1002/cne.21584
King, 2006, The rise, fall, and resurrection of the ventromedial hypothalamus in the regulation of feeding behavior and body weight, Physiol Behav, 87, 221, 10.1016/j.physbeh.2005.10.007
Gold, 1973, Hypothalamic obesity: the myth of the ventromedial nucleus, Science, 182, 488, 10.1126/science.182.4111.488
Ikeda, 1995, The nuclear receptor steroidogenic factor 1 is essential for the formation of the ventromedial hypothalamic nucleus, Mol Endocrinol, 9, 478
Dellovade, 2000, Disruption of the gene encoding SF-1 alters the distribution of hypothalamic neuronal phenotypes, J Comp Neurol, 423, 579, 10.1002/1096-9861(20000807)423:4<579::AID-CNE4>3.0.CO;2-#
Majdic, 2002, Knockout mice lacking steroidogenic factor 1 are a novel genetic model of hypothalamic obesity, Endocrinology, 143, 607, 10.1210/endo.143.2.8652
Minami, 1990, 17 β-Estradiol depolarization of hypothalamic neurons is mediated by cyclic AMP, Brain Res, 519, 301, 10.1016/0006-8993(90)90092-P
Musatov, 2007, Silencing of estrogen receptor α in the ventromedial nucleus of hypothalamus leads to metabolic syndrome, Proc Natl Acad Sci USA, 104, 2501, 10.1073/pnas.0610787104
Schlenker, 2006, Sex-specific densities of estrogen receptors α and β in the subnuclei of the nucleus tractus solitarius, hypoglossal nucleus and dorsal vagal motor nucleus weanling rats, Brain Res, 1123, 89, 10.1016/j.brainres.2006.09.035
Asarian, 2007, Estradiol enhances cholecystokinin-dependent lipid-induced satiation and activates estrogen receptor-α-expressing cells in the nucleus tractus solitarius of ovariectomized rats, Endocrinology, 148, 5656, 10.1210/en.2007-0341
Moran, 2009, Gut peptides in the control of food intake, Int J Obes (Lond), 33, S7, 10.1038/ijo.2009.9
Degen, 2001, The effect of cholecystokinin in controlling appetite and food intake in humans, Peptides, 22, 1265, 10.1016/S0196-9781(01)00450-8
Geary, 1996, The increased satiating potency of CCK-8 by estradiol is not mediated by upregulation of NTS CCK receptors, Brain Res, 719, 179, 10.1016/0006-8993(96)00099-6
Linden, 1990, Involvement of cholecystokinin in food intake. III. Oestradiol potentiates the inhibitory effect of cholecystokinin octapeptide on food intake in ovariectomized rats, J Neuroendocrinol, 2, 797, 10.1111/j.1365-2826.1990.tb00643.x
Butera, 1993, Modulation of the satiety effect of cholecystokinin by estradiol, Physiol Behav, 53, 1235, 10.1016/0031-9384(93)90387-U
Asarian, 1999, Cyclic estradiol treatment phasically potentiates endogenous cholecystokinin's satiating action in ovariectomized rats, Peptides, 20, 445, 10.1016/S0196-9781(99)00024-8
Thammacharoen, 2008, Hindbrain administration of estradiol inhibits feeding and activates estrogen receptor-α-expressing cells in the nucleus tractus solitarius of ovariectomized rats, Endocrinology, 149, 1609, 10.1210/en.2007-0340
Zhang, 1994, Positional cloning of the mouse obese gene and its human homologue, Nature, 372, 425, 10.1038/372425a0
Myers, 2010, Obesity and leptin resistance: distinguishing cause from effect, Trends Endocrinol Metab, 21, 643, 10.1016/j.tem.2010.08.002
van Dijk, 1996, Central infusion of leptin and GLP-1 (7–36) amide differentially stimulate c-Fos-like immunoreactivity in the rat brain, Am J Physiol, 271, R1096
Elmquist, 1998, Leptin activates distinct projections from the dorsomedial and ventromedial hypothalamic nuclei, Proc Natl Acad Sci USA, 95, 741, 10.1073/pnas.95.2.741
Elmquist, 1998, Distributions of leptin receptor mRNA isoforms in the rat brain, J Comp Neurol, 395, 535, 10.1002/(SICI)1096-9861(19980615)395:4<535::AID-CNE9>3.0.CO;2-2
Diano, 1998, Leptin receptors in estrogen receptor-containing neurons of the female rat hypothalamus, Brain Res, 812, 256, 10.1016/S0006-8993(98)00936-6
Bennett, 1999, Cyclical variations in the abundance of leptin receptors, but not in circulating leptin, correlate with NPY expression during the oestrous cycle, Neuroendocrinology, 69, 417, 10.1159/000054444
Lindell, 2001, Leptin receptor 5′untranslated regions in the rat: relative abundance, genomic organization and relation to putative response elements, Mol Cell Endocrinol, 172, 37, 10.1016/S0303-7207(00)00382-8
Ainslie, 2001, Estrogen deficiency causes central leptin insensitivity and increased hypothalamic neuropeptide Y, Int J Obes Relat Metab Disord, 25, 1680, 10.1038/sj.ijo.0801806
Clegg, 2003, Differential sensitivity to central leptin and insulin in male and female rats, Diabetes, 52, 682, 10.2337/diabetes.52.3.682
Clegg, 2006, Gonadal hormones determine sensitivity to central leptin and insulin, Diabetes, 55, 978, 10.2337/diabetes.55.04.06.db05-1339
Chavez, 1995, 1995 ventricular insulin infusion attenuates NPY-induced feeding at the level of the paraventricular nucleus, Obes Res, 3, 335s
Levin, 1999, Arcuate NPY neurons and energy homeostasis in diet-induced obese and resistant rats, Am J Physiol, 276, R382
Cone, 2001, The arcuate nucleus as a conduit for diverse signals relevant to energy homeostasis, Int J Obes Relat Metab Disord, 25, S63, 10.1038/sj.ijo.0801913
Herzog, 2003, Neuropeptide Y and energy homeostasis: insights from Y receptor knockout models, Eur J Pharmacol, 480, 21, 10.1016/j.ejphar.2003.08.089
Baskin, 1999, Leptin receptor long-form splice-variant protein expression in neuron cell bodies of the brain and colocalization with neuropeptide Y mRNA in the arcuate nucleus, J Histochem Cytochem, 47, 353, 10.1177/002215549904700309
Hill, 2004, Estrogen induces neuropeptide Y (NPY) Y1 receptor gene expression and responsiveness to NPY in gonadotrope-enriched pituitary cell cultures, Endocrinology, 145, 2283, 10.1210/en.2003-1368
Bonavera, 1994, Anorectic effects of estrogen may be mediated by decreased neuropeptide-Y release in the hypothalamic paraventricular nucleus, Endocrinology, 134, 2367, 10.1210/endo.134.6.8194462
Titolo, 2006, Coordinate regulation of neuropeptide Y and agouti-related peptide gene expression by estrogen depends on the ratio of estrogen receptor (ER) α to ERβ in clonal hypothalamic neurons, Mol Endocrinol, 20, 2080, 10.1210/me.2006-0027
Olofsson, 2009, Functional requirement of AgRP and NPY neurons in ovarian cycle-dependent regulation of food intake, Proc Natl Acad Sci USA, 106, 15932, 10.1073/pnas.0904747106
Bouchard, 1993, Genetic and nongenetic determinants of regional fat distribution, Endocr Rev, 14, 72, 10.1210/edrv-14-1-72
Enzi, 1986, Subcutaneous and visceral fat distribution according to sex, age, and overweight, evaluated by computed tomography, Am J Clin Nutr, 44, 739, 10.1093/ajcn/44.6.739
Bjorntorp, 1992, Abdominal fat distribution and disease: an overview of epidemiological data, Ann Med, 24, 15, 10.3109/07853899209164140
Bjorntorp, 1992, Abdominal fat distribution and the metabolic syndrome, J Cardiovasc Pharmacol, 20, S26, 10.1097/00005344-199200208-00006
Bjørntorp, 1992, Hormonal effects on fat distribution and its relationship to health risk factors, Acta Paediatr Suppl, 383, 59
Guthrie, 2004, The menopausal transition: a 9-year prospective population-based study. The Melbourne Women's Midlife Health Project, Climacteric, 7, 375, 10.1080/13697130400012163
Lovejoy, 2008, Increased visceral fat and decreased energy expenditure during the menopausal transition, Int J Obes (Lond), 32, 949, 10.1038/ijo.2008.25
Gambacciani, 1997, Body weight, body fat distribution, and hormonal replacement therapy in early postmenopausal women, J Clin Endocrinol Metab, 82, 414, 10.1210/jcem.82.2.3735
Haarbo, 1991, Hormone replacement therapy prevents coronary artery disease in ovariectomized cholesterol-fed rabbits, APMIS, 99, 721, 10.1111/j.1699-0463.1991.tb01250.x
Haarbo, 1991, Postmenopausal hormone replacement therapy prevents central distribution of body fat after menopause, Metabolism, 40, 1323, 10.1016/0026-0495(91)90037-W
Elbers, 1999, Effects of sex steroid hormones on regional fat depots as assessed by magnetic resonance imaging in transsexuals, Am J Physiol, 276, E317
Wajchenberg, 2000, Subcutaneous and visceral adipose tissue: their relation to the metabolic syndrome, Endocr Rev, 21, 697, 10.1210/edrv.21.6.0415
Thorne, 2002, A pilot study of long-term effects of a novel obesity treatment: omentectomy in connection with adjustable gastric banding, Int J Obes Relat Metab Disord, 26, 193, 10.1038/sj.ijo.0801871
Herrera, 2010, Potential additional effect of omentectomy on metabolic syndrome, acute-phase reactants, and inflammatory mediators in grade III obese patients undergoing laparoscopic Roux-en-Y gastric bypass: a randomized trial, Diabetes Care, 33, 1413, 10.2337/dc09-1833
Fabbrini, 2010, Surgical removal of omental fat does not improve insulin sensitivity and cardiovascular risk factors in obese adults, Gastroenterology, 139, 448, 10.1053/j.gastro.2010.04.056
Gabriely, 2002, Removal of visceral fat prevents insulin resistance and glucose intolerance of aging: an adipokine-mediated process?, Diabetes, 51, 2951, 10.2337/diabetes.51.10.2951
Lapidus, 1984, Distribution of adipose tissue and risk of cardiovascular disease and death: a 12 year follow up of participants in the population study of women in Gothenburg, Sweden, Br Med J (Clin Res Ed), 289, 1257, 10.1136/bmj.289.6454.1257
Donahue, 1987, Sex differences in the coronary heart disease risk profile: a possible role for insulin. The Beaver County Study, Am J Epidemiol, 125, 650, 10.1093/oxfordjournals.aje.a114578
Donahue, 1987, Central obesity and coronary heart disease in men, Lancet, 2, 1215, 10.1016/S0140-6736(87)91357-2
Ohlson, 1985, The influence of body fat distribution on the incidence of diabetes mellitus: 13.5 years of follow-up of the participants in the study of men born in 1913, Diabetes, 34, 1055, 10.2337/diab.34.10.1055
Bjorntorp, 1996, The android woman—a risky condition, J Intern Med, 239, 105, 10.1046/j.1365-2796.1996.364690000.x
Tran, 2008, Beneficial effects of subcutaneous fat transplantation on metabolism, Cell Metab, 7, 410, 10.1016/j.cmet.2008.04.004
Schneider, 1979, Increased estrogen production in obese men, J Clin Endocrinol Metab, 48, 633, 10.1210/jcem-48-4-633
Tchernof, 1995, Relation of steroid hormones to glucose tolerance and plasma insulin levels in men. Importance of visceral adipose tissue, Diabetes Care, 18, 292, 10.2337/diacare.18.3.292
Mizutani, 1994, Identification of estrogen receptor in human adipose tissue and adipocytes, J Clin Endocrinol Metab, 78, 950
Price, 1993, Determination of estrogen receptor messenger ribonucleic acid (mRNA) and cytochrome P450 aromatase mRNA levels in adipocytes and adipose stromal cells by competitive polymerase chain reaction amplification, J Clin Endocrinol Metab, 77, 1041
Ogawa, 1999, Survival of reproductive behaviors in estrogen receptor β gene-deficient (βERKO) male and female mice, Proc Natl Acad Sci USA, 96, 12887, 10.1073/pnas.96.22.12887
Smith, 1994, Estrogen resistance caused by a mutation in the estrogen-receptor gene in a man, N Engl J Med, 331, 1056, 10.1056/NEJM199410203311604
Okura, 2003, Association of polymorphisms in the estrogen receptor α gene with body fat distribution, Int J Obes Relat Metab Disord, 27, 1020, 10.1038/sj.ijo.0802378
Nilsson, 2007, Oestrogen receptor α gene expression levels are reduced in obese compared to normal weight females, Int J Obes (Lond), 31, 900, 10.1038/sj.ijo.0803528
Deng, 2000, Association of estrogen receptor-α genotypes with body mass index in normal healthy postmenopausal Caucasian women, J Clin Endocrinol Metab, 85, 2748
Casazza, 2010, The association between the rs2234693 and rs9340799 estrogen receptor α gene polymorphisms and risk factors for cardiovascular disease: a review, Biol Res Nurs, 12, 84, 10.1177/1099800410371118
Yamada, 2002, Association of polymorphisms of the estrogen receptor α gene with bone mineral density of the femoral neck in elderly Japanese women, J Mol Med, 80, 452, 10.1007/s00109-002-0348-0
Okura, 2003, Relationships of resting energy expenditure with body fat distribution and abdominal fatness in Japanese population, J Physiol Anthropol Appl Human Sci, 22, 47, 10.2114/jpa.22.47
Okura, 2003, Association of the mitochondrial DNA 15497G/A polymorphism with obesity in a middle-aged and elderly Japanese population, Hum Genet, 113, 432, 10.1007/s00439-003-0983-8
D'Eon, 2005, Estrogen regulation of adiposity and fuel partitioning. Evidence of genomic and non-genomic regulation of lipogenic and oxidative pathways, J Biol Chem, 280, 35983, 10.1074/jbc.M507339200
Lundholm, 2008, Key lipogenic gene expression can be decreased by estrogen in human adipose tissue, Fertil Steril, 90, 44, 10.1016/j.fertnstert.2007.06.011
Price, 1998, Estrogen regulation of adipose tissue lipoprotein lipase—possible mechanism of body fat distribution, Am J Obstet Gynecol, 178, 101, 10.1016/S0002-9378(98)70634-9
Bryzgalova, 2008, Mechanisms of antidiabetogenic and body weight-lowering effects of estrogen in high-fat diet-fed mice, Am J Physiol Endocrinol Metab, 295, E904, 10.1152/ajpendo.90248.2008
Gao, 2006, Long-term administration of estradiol decreases expression of hepatic lipogenic genes and improves insulin sensitivity in ob/ob mice: a possible mechanism is through direct regulation of signal transducer and activator of transcription 3, Mol Endocrinol, 20, 1287, 10.1210/me.2006-0012
Lundholm, 2008, The estrogen receptor α-selective agonist propyl pyrazole triol improves glucose tolerance in ob/ob mice; potential molecular mechanisms, J Endocrinol, 199, 275, 10.1677/JOE-08-0192
Semenkovich, 1989, Insulin regulation of lipoprotein lipase activity in 3T3–L1 adipocytes is mediated at posttranscriptional and posttranslational levels, J Biol Chem, 264, 9030, 10.1016/S0021-9258(18)81898-1
Iverius, 1988, Relationship between lipoprotein lipase activity and plasma sex steroid level in obese women, J Clin Invest, 82, 1106, 10.1172/JCI113667
Urabe, 1996, Effect of estrogen replacement therapy on hepatic triglyceride lipase, lipoprotein lipase and lipids including apolipoprotein E in climacteric and elderly women, Endocr J, 43, 737, 10.1507/endocrj.43.737
Homma, 2000, Estrogen suppresses transcription of lipoprotein lipase gene. Existence of a unique estrogen response element on the lipoprotein lipase promoter, J Biol Chem, 275, 11404, 10.1074/jbc.275.15.11404
Miranda, 2007, Human subcutaneous adipose tissue LPIN1 expression in obesity, type 2 diabetes mellitus, and human immunodeficiency virus–associated lipodystrophy syndrome, Metabolism, 56, 1518, 10.1016/j.metabol.2007.06.019
van Harmelen, 2007, A role of lipin in human obesity and insulin resistance: relation to adipocyte glucose transport and GLUT4 expression, J Lipid Res, 48, 201, 10.1194/jlr.M600272-JLR200
Gonzalez, 2012, Regulation of lipin1 by nutritional status, adiponectin, sex and pituitary function in rat white adipose tissue, Physiol Behav, 105, 777, 10.1016/j.physbeh.2011.10.016
Cooke, 2004, Role of estrogens in adipocyte development and function, Exp Biol Med (Maywood), 229, 1127, 10.1177/153537020422901107
Foryst-Ludwig, 2008, Metabolic actions of estrogen receptor β (ERβ) are mediated by a negative cross-talk with PPARγ, PLoS Genet, 4, e1000108, 10.1371/journal.pgen.1000108
Park, 2003, The metabolic syndrome: prevalence and associated risk factor findings in the US population from the Third National Health and Nutrition Examination Survey, 1988–1994, Arch Intern Med, 163, 427, 10.1001/archinte.163.4.427
Hevener, 2007, Macrophage PPAR γ is required for normal skeletal muscle and hepatic insulin sensitivity and full antidiabetic effects of thiazolidinediones, J Clin Invest, 117, 1658, 10.1172/JCI31561
Choi, 2007, Overexpression of uncoupling protein 3 in skeletal muscle protects against fat-induced insulin resistance, J Clin Invest, 117, 1995, 10.1172/JCI13579
Frias, 2001, Decreased susceptibility to fatty acid-induced peripheral tissue insulin resistance in women, Diabetes, 50, 1344, 10.2337/diabetes.50.6.1344
Hevener, 2002, Female rats do not exhibit free fatty acid-induced insulin resistance, Diabetes, 51, 1907, 10.2337/diabetes.51.6.1907
Djouadi, 1998, A gender-related defect in lipid metabolism and glucose homeostasis in peroxisome proliferator-activated receptor α-deficient mice, J Clin Invest, 102, 1083, 10.1172/JCI3949
Hong, 2009, Differential susceptibility to obesity between male, female and ovariectomized female mice, Nutr J, 8, 11, 10.1186/1475-2891-8-11
Pfeilschifter, 2002, Changes in proinflammatory cytokine activity after menopause, Endocr Rev, 23, 90, 10.1210/edrv.23.1.0456
Sites, 2002, Menopause-related differences in inflammation markers and their relationship to body fat distribution and insulin-stimulated glucose disposal, Fertil Steril, 77, 128, 10.1016/S0015-0282(01)02934-X
Campbell, 2002, Effect of the ovarian hormones on GLUT4 expression and contraction-stimulated glucose uptake, Am J Physiol Endocrinol Metab, 282, E1139, 10.1152/ajpendo.00184.2001
Stubbins, 2012, Estrogen modulates abdominal adiposity and protects female mice from obesity and impaired glucose tolerance, Eur J Nutr, 51, 861, 10.1007/s00394-011-0266-4
Rogers, 2009, Estradiol stimulates Akt, AMP-activated protein kinase (AMPK) and TBC1D1/4, but not glucose uptake in rat soleus, Biochem Biophys Res Commun, 382, 646, 10.1016/j.bbrc.2009.02.154
Gorres, 2011, In vivo stimulation of oestrogen receptor α increases insulin-stimulated skeletal muscle glucose uptake, J Physiol, 589, 2041, 10.1113/jphysiol.2010.199018
Van Pelt, 2003, Intravenous estrogens increase insulin clearance and action in postmenopausal women, Am J Physiol Endocrinol Metab, 285, E311, 10.1152/ajpendo.00490.2002
Alonso, 2010, Acute effects of 17 β-estradiol and genistein on insulin sensitivity and spatial memory in aged ovariectomized female rats, Age (Dordr), 32, 421, 10.1007/s11357-010-9148-6
Salehzadeh, 2011, Testosterone or 17β-estradiol exposure reveals sex-specific effects on glucose and lipid metabolism in human myotubes, J Endocrinol, 210, 219, 10.1530/JOE-10-0497
Rochira, 2007, Oestradiol replacement treatment and glucose homeostasis in two men with congenital aromatase deficiency: evidence for a role of oestradiol and sex steroids imbalance on insulin sensitivity in men, Diabet Med, 24, 1491, 10.1111/j.1464-5491.2007.02304.x
Guercio, 2009, Metformin, estrogen replacement therapy and gonadotropin inhibition fail to improve insulin sensitivity in a girl with aromatase deficiency, Horm Res, 72, 370
Takeda, 2003, Progressive development of insulin resistance phenotype in male mice with complete aromatase (CYP19) deficiency, J Endocrinol, 176, 237, 10.1677/joe.0.1760237
Maffei, 2004, Dysmetabolic syndrome in a man with a novel mutation of the aromatase gene: effects of testosterone, alendronate, and estradiol treatment, J Clin Endocrinol Metab, 89, 61, 10.1210/jc.2003-030313
Maffei, 2007, A novel compound heterozygous mutation of the aromatase gene in an adult man: reinforced evidence on the relationship between congenital oestrogen deficiency, adiposity and the metabolic syndrome, Clin Endocrinol (Oxf), 67, 218, 10.1111/j.1365-2265.2007.02864.x
Jones, 2007, Estrogen and adiposity—utilizing models of aromatase deficiency to explore the relationship, J Steroid Biochem Mol Biol, 106, 3, 10.1016/j.jsbmb.2007.05.029
Morishima, 1995, Aromatase deficiency in male and female siblings caused by a novel mutation and the physiological role of estrogens, J Clin Endocrinol Metab, 80, 3689
Nadal, 2009, The pancreatic β-cell as a target of estrogens and xenoestrogens: implications for blood glucose homeostasis and diabetes, Mol Cell Endocrinol, 304, 63, 10.1016/j.mce.2009.02.016
Barros, 2008, Insulin resistance of pregnancy involves estrogen-induced repression of muscle GLUT4, Mol Cell Endocrinol, 295, 24, 10.1016/j.mce.2008.07.008
Ding, 2007, Plasma sex steroid hormones and risk of developing type 2 diabetes in women: a prospective study, Diabetologia, 50, 2076, 10.1007/s00125-007-0785-y
Kalyani, 2009, The association of endogenous sex hormones, adiposity, and insulin resistance with incident diabetes in postmenopausal women, J Clin Endocrinol Metab, 94, 4127, 10.1210/jc.2009-0910
Wiik, 2005, Expression of oestrogen receptor α and β is higher in skeletal muscle of highly endurance-trained than of moderately active men, Acta Physiol Scand, 184, 105, 10.1111/j.1365-201X.2005.01433.x
Baltgalvis, 2010, Estrogen regulates estrogen receptors and antioxidant gene expression in mouse skeletal muscle, PLoS One, 5, e10164, 10.1371/journal.pone.0010164
Perry, 2010, Genetic evidence that raised sex hormone binding globulin (SHBG) levels reduce the risk of type 2 diabetes, Hum Mol Genet, 19, 535, 10.1093/hmg/ddp522
Ribas, 2010, Impaired oxidative metabolism and inflammation are associated with insulin resistance in ERα-deficient mice, Am J Physiol Endocrinol Metab, 298, E304, 10.1152/ajpendo.00504.2009
Riant, 2009, Estrogens protect against high-fat diet-induced insulin resistance and glucose intolerance in mice, Endocrinology, 150, 2109, 10.1210/en.2008-0971
Bryzgalova, 2006, Evidence that oestrogen receptor-α plays an important role in the regulation of glucose homeostasis in mice: insulin sensitivity in the liver, Diabetologia, 49, 588, 10.1007/s00125-005-0105-3
Ribas, 2010, Skeletal muscle specific ERα deletion is causal for the metabolic syndrome, Endocr Rev, 31, S5
Barros, 2006, Muscle GLUT4 regulation by estrogen receptors ERβ and ERα, Proc Natl Acad Sci USA, 103, 1605, 10.1073/pnas.0510391103
Campbell, 2003, 17β-Estradiol upregulates the expression of peroxisome proliferator-activated receptor α and lipid oxidative genes in skeletal muscle, J Mol Endocrinol, 31, 37, 10.1677/jme.0.0310037
Alonso, 2009, 17β-Estradiol treatment is unable to reproduce p85 α redistribution associated with gestational insulin resistance in rats, J Steroid Biochem Mol Biol, 116, 160, 10.1016/j.jsbmb.2009.05.010
Hansen, 1996, Effects of ovariectomy and exercise training on muscle GLUT-4 content and glucose metabolism in rats, J Appl Physiol, 80, 1605, 10.1152/jappl.1996.80.5.1605
Barros, 2011, Estrogen receptors and the metabolic network, Cell Metab, 14, 289, 10.1016/j.cmet.2011.08.005
Murgia, 2009, Multiple signalling pathways redundantly control glucose transporter GLUT4 gene transcription in skeletal muscle, J Physiol, 587, 4319, 10.1113/jphysiol.2009.174888
Zorzano, 2005, Mechanisms regulating GLUT4 glucose transporter expression and glucose transport in skeletal muscle, Acta Physiol Scand, 183, 43, 10.1111/j.1365-201X.2004.01380.x
Fu, 2009, Exercise, sex, menstrual cycle phase, and 17β-estradiol influence metabolism-related genes in human skeletal muscle, Physiol Genomics, 40, 34, 10.1152/physiolgenomics.00115.2009
Hoeg, 2009, Higher intramuscular triacylglycerol in women does not impair insulin sensitivity and proximal insulin signaling, J Appl Physiol, 107, 824, 10.1152/japplphysiol.91382.2008
Garvey, 1998, Evidence for defects in the trafficking and translocation of GLUT4 glucose transporters in skeletal muscle as a cause of human insulin resistance, J Clin Invest, 101, 2377, 10.1172/JCI1557
Garvey, 1992, Gene expression of GLUT4 in skeletal muscle from insulin-resistant patients with obesity, IGT, GDM, and NIDDM, Diabetes, 41, 465, 10.2337/diab.41.4.465
Banks, 1992, Muscle glucose transport, GLUT-4 content, and degree of exercise training in obese Zucker rats, Am J Physiol, 263, E1010
Brozinick, 1993, Effects of exercise training on muscle GLUT-4 protein content and translocation in obese Zucker rats, Am J Physiol, 265, E419
Brozinick, 1994, Glucose uptake and GLUT-4 protein distribution in skeletal muscle of the obese Zucker rat, Am J Physiol, 267, R236
Hevener, 2000, Exercise and thiazolidinedione therapy normalize insulin action in the obese Zucker fatty rat, Diabetes, 49, 2154, 10.2337/diabetes.49.12.2154
Dela, 1994, Physical training increases muscle GLUT4 protein and mRNA in patients with NIDDM, Diabetes, 43, 862, 10.2337/diab.43.7.862
Rodnick, 1990, Effects of exercise training on insulin-regulatable glucose-transporter protein levels in rat skeletal muscle, Diabetes, 39, 1425, 10.2337/diab.39.11.1425
Lemoine, 2002, Effect of endurance training on oestrogen receptor α expression in different rat skeletal muscle type, Acta Physiol Scand, 175, 211, 10.1046/j.1365-201X.2002.00992.x
Lemoine, 2002, Effect of endurance training on oestrogen receptor α transcripts in rat skeletal muscle, Acta Physiol Scand, 174, 283, 10.1046/j.1365-201x.2002.00943.x
Mora, 2000, The MEF2A isoform is required for striated muscle-specific expression of the insulin-responsive GLUT4 glucose transporter, J Biol Chem, 275, 16323, 10.1074/jbc.M910259199
van Rooij, 2010, Myocyte enhancer factor 2 and class II histone deacetylases control a gender-specific pathway of cardioprotection mediated by the estrogen receptor, Circ Res, 106, 155, 10.1161/CIRCRESAHA.109.207084
Moreno, 2003, Differential regulation of the muscle-specific GLUT4 enhancer in regenerating and adult skeletal muscle, J Biol Chem, 278, 40557, 10.1074/jbc.M306609200
Gan, 2011, The nuclear receptor PPARβ/δ programs muscle glucose metabolism in cooperation with AMPK and MEF2, Genes Dev, 25, 2619, 10.1101/gad.178434.111
Oshel, 2000, Identification of a 30-base pair regulatory element and novel DNA binding protein that regulates the human GLUT4 promoter in transgenic mice, J Biol Chem, 275, 23666, 10.1074/jbc.M001452200
Smith, 2008, CaMK activation during exercise is required for histone hyperacetylation and MEF2A binding at the MEF2 site on the Glut4 gene, Am J Physiol Endocrinol Metab, 295, E698, 10.1152/ajpendo.00747.2007
Gong, 2011, MEF2A binding to the Glut4 promoter occurs via an AMPKα2-dependent mechanism, Med Sci Sports Exerc, 43, 1441, 10.1249/MSS.0b013e31820f6093
Ordonez, 2008, 17β-Estradiol and/or progesterone protect from insulin resistance in STZ-induced diabetic rats, J Steroid Biochem Mol Biol, 111, 287, 10.1016/j.jsbmb.2008.07.001
Galluzzo, 2009, 17β-Estradiol regulates the first steps of skeletal muscle cell differentiation via ER-α-mediated signals, Am J Physiol Cell Physiol, 297, C1249, 10.1152/ajpcell.00188.2009
Stitt, 2004, The IGF-1/PI3K/Akt pathway prevents expression of muscle atrophy-induced ubiquitin ligases by inhibiting FOXO transcription factors, Mol Cell, 14, 395, 10.1016/S1097-2765(04)00211-4
Enns, 2008, Oestrogen receptors mediate oestrogen-induced increases in post-exercise rat skeletal muscle satellite cells, Acta Physiol (Oxf), 194, 81, 10.1111/j.1748-1716.2008.01861.x
Enns, 2008, Estrogen influences satellite cell activation and proliferation following downhill running in rats, J Appl Physiol, 104, 347, 10.1152/japplphysiol.00128.2007
Thomas, 2010, Oestrogen receptor-α activation augments post-exercise myoblast proliferation, Acta Physiol (Oxf), 198, 81, 10.1111/j.1748-1716.2009.02033.x
Kamanga-Sollo, 2010, Effect of estradiol-17β on protein synthesis and degradation rates in fused bovine satellite cell cultures, Domest Anim Endocrinol, 39, 54, 10.1016/j.domaniend.2010.02.002
Lee, 2005, Up-regulation of PI3K/Akt signaling by 17β-estradiol through activation of estrogen receptor-α, but not estrogen receptor-β, and stimulates cell growth in breast cancer cells, Biochem Biophys Res Commun, 336, 1221, 10.1016/j.bbrc.2005.08.256
Noh, 2011, Estrogen receptor α induces down-regulation of PTEN through PI3-kinase activation in breast cancer cells, Mol Med Report, 4, 215
Simoncini, 2000, Interaction of oestrogen receptor with the regulatory subunit of phosphatidylinositol-3-OH kinase, Nature, 407, 538, 10.1038/35035131
Simoncini, 2002, Novel non-transcriptional mechanisms for estrogen receptor signaling in the cardiovascular system. Interaction of estrogen receptor α with phosphatidylinositol 3-OH kinase, Steroids, 67, 935, 10.1016/S0039-128X(02)00040-5
Mannella, 2006, Estrogen receptor protein interaction with phosphatidylinositol 3-kinase leads to activation of phosphorylated Akt and extracellular signal-regulated kinase 1/2 in the same population of cortical neurons: a unified mechanism of estrogen action, J Neurosci, 26, 9439, 10.1523/JNEUROSCI.1443-06.2006
Ronda, 2010, Extracellular-regulated kinase and p38 mitogen-activated protein kinases are involved in the antiapoptotic action of 17β-estradiol in skeletal muscle cells, J Endocrinol, 206, 235, 10.1677/JOE-09-0429
Ronda, 2010, Role of estrogen receptors, PKC and Src in ERK2 and p38 MAPK signaling triggered by 17β-estradiol in skeletal muscle cells, J Steroid Biochem Mol Biol, 122, 287, 10.1016/j.jsbmb.2010.05.002
Niu, 2003, Maturation of the regulation of GLUT4 activity by p38 MAPK during L6 cell myogenesis, J Biol Chem, 278, 17953, 10.1074/jbc.M211136200
Furtado, 2002, Activation of the glucose transporter GLUT4 by insulin, Biochem Cell Biol, 80, 569, 10.1139/o02-156
Sweeney, 1999, An inhibitor of p38 mitogen-activated protein kinase prevents insulin-stimulated glucose transport but not glucose transporter translocation in 3T3–L1 adipocytes and L6 myotubes, J Biol Chem, 274, 10071, 10.1074/jbc.274.15.10071
Sorensen, 2001, Obesity and sarcopenia after menopause are reversed by sex hormone replacement therapy, Obes Res, 9, 622, 10.1038/oby.2001.81
Leger, 2008, Human sarcopenia reveals an increase in SOCS-3 and myostatin and a reduced efficiency of Akt phosphorylation, Rejuvenation Res, 11, 163, 10.1089/rej.2007.0588
Tiidus, 2000, Estrogen and gender effects on muscle damage, inflammation, and oxidative stress, Can J Appl Physiol, 25, 274, 10.1139/h00-022
Messier, 2011, Menopause and sarcopenia: a potential role for sex hormones, Maturitas, 68, 331, 10.1016/j.maturitas.2011.01.014
Chen, 2005, Postmenopausal hormone therapy and body composition—a substudy of the estrogen plus progestin trial of the Women's Health Initiative, Am J Clin Nutr, 82, 651, 10.1093/ajcn/82.3.651
Sipila, 2001, Effects of hormone replacement therapy and high-impact physical exercise on skeletal muscle in post-menopausal women: a randomized placebo-controlled study, Clin Sci (Lond), 101, 147, 10.1042/cs1010147
Teixeira, 2003, Resistance training in postmenopausal women with and without hormone therapy, Med Sci Sports Exerc, 35, 555, 10.1249/01.MSS.0000058437.17262.11
Dieli-Conwright, 2009, Hormone therapy attenuates exercise-induced skeletal muscle damage in postmenopausal women, J Appl Physiol, 107, 853, 10.1152/japplphysiol.00404.2009
Sotiriadou, 2006, Soleus muscle force following downhill running in ovariectomized rats treated with estrogen, Appl Physiol Nutr Metab, 31, 449, 10.1139/h06-008
Boland, 2008, 17β-Estradiol signaling in skeletal muscle cells and its relationship to apoptosis, Steroids, 73, 859, 10.1016/j.steroids.2007.12.027
Vasconsuelo, 2008, 17β-Estradiol abrogates apoptosis in murine skeletal muscle cells through estrogen receptors: role of the phosphatidylinositol 3-kinase/Akt pathway, J Endocrinol, 196, 385, 10.1677/JOE-07-0250
Wang, 2010, Female adult mouse cardiomyocytes are protected against oxidative stress, Hypertension, 55, 1172, 10.1161/HYPERTENSIONAHA.110.150839
McLoughlin, 2009, FoxO1 induces apoptosis in skeletal myotubes in a DNA-binding-dependent manner, Am J Physiol Cell Physiol, 297, C548, 10.1152/ajpcell.00502.2008
Naaz, 2002, Effect of ovariectomy on adipose tissue of mice in the absence of estrogen receptor α (ERα): a potential role for estrogen receptor β (ERβ), Horm Metab Res, 34, 758, 10.1055/s-2002-38259
Barros, 2009, Participation of ERα and ERβ in glucose homeostasis in skeletal muscle and white adipose tissue, Am J Physiol Endocrinol Metab, 297, E124, 10.1152/ajpendo.00189.2009
Hoeg, 2011, Lipid-induced insulin resistance affects women less than men and is not accompanied by inflammation or impaired proximal insulin signaling, Diabetes, 60, 64, 10.2337/db10-0698
Cortright, 2000, Sex differences in substrate metabolism and energy homeostasis, Can J Appl Physiol, 25, 288, 10.1139/h00-023
Amati, 2011, Skeletal muscle triglycerides, diacylglycerols, and ceramides in insulin resistance: another paradox in endurance-trained athletes?, Diabetes, 60, 2588, 10.2337/db10-1221
Maher, 2010, Women have higher protein content of β-oxidation enzymes in skeletal muscle than men, PLoS One, 5, e12025, 10.1371/journal.pone.0012025
Turcotte, 1992, Increased plasma FFA uptake and oxidation during prolonged exercise in trained vs. untrained humans, Am J Physiol, 262, E791
Hamadeh, 2005, Estrogen supplementation reduces whole body leucine and carbohydrate oxidation and increases lipid oxidation in men during endurance exercise, J Clin Endocrinol Metab, 90, 3592, 10.1210/jc.2004-1743
Maher, 2010, Men supplemented with 17β-estradiol have increased β-oxidation capacity in skeletal muscle, Physiol Genomics, 42, 342, 10.1152/physiolgenomics.00016.2010
D'Eon, 2008, Estradiol and the estradiol metabolite, 2-hydroxyestradiol, activate AMP-activated protein kinase in C2C12 myotubes, Obesity (Silver Spring), 16, 1284, 10.1038/oby.2008.50
Mihaylova, 2011, The AMPK signalling pathway coordinates cell growth, autophagy and metabolism, Nat Cell Biol, 13, 1016, 10.1038/ncb2329
Hardie, 2011, AMP-activated protein kinase: an energy sensor that regulates all aspects of cell function, Genes Dev, 25, 1895, 10.1101/gad.17420111
Kim, 2010, Parenteral 17β-estradiol decreases fasting blood glucose levels in non-obese mice with short-term ovariectomy, Life Sci, 87, 358, 10.1016/j.lfs.2010.07.009
Itani, 2002, Lipid-induced insulin resistance in human muscle is associated with changes in diacylglycerol, protein kinase C, and IκB-α, Diabetes, 51, 2005, 10.2337/diabetes.51.7.2005
Adams, 2004, Ceramide content is increased in skeletal muscle from obese insulin-resistant humans, Diabetes, 53, 25, 10.2337/diabetes.53.1.25
Yang, 2009, Central role of ceramide biosynthesis in body weight regulation, energy metabolism, and the metabolic syndrome, Am J Physiol Endocrinol Metab, 297, E211, 10.1152/ajpendo.91014.2008
Summers, 2006, Ceramides in insulin resistance and lipotoxicity, Prog Lipid Res, 45, 42, 10.1016/j.plipres.2005.11.002
Holland, 2007, Inhibition of ceramide synthesis ameliorates glucocorticoid-, saturated-fat-, and obesity-induced insulin resistance, Cell Metab, 5, 167, 10.1016/j.cmet.2007.01.002
Holland, 2007, Lipid mediators of insulin resistance, Nutr Rev, 65, S39, 10.1301/nr.2007.jun.S39-S46
Hotamisligil, 2008, Inflammation and endoplasmic reticulum stress in obesity and diabetes, Int J Obes (Lond), 32, S52, 10.1038/ijo.2008.238
Borras, 2003, Mitochondria from females exhibit higher antioxidant gene expression and lower oxidative damage than males, Free Radic Biol Med, 34, 546, 10.1016/S0891-5849(02)01356-4
Chung, 2009, Glutathione peroxidase 3 mediates the antioxidant effect of peroxisome proliferator-activated receptor γ in human skeletal muscle cells, Mol Cell Biol, 29, 20, 10.1128/MCB.00544-08
Yang, 2009, Validation of candidate causal genes for obesity that affect shared metabolic pathways and networks, Nat Genet, 41, 415, 10.1038/ng.325
Patti, 2003, Coordinated reduction of genes of oxidative metabolism in humans with insulin resistance and diabetes: potential role of PGC1 and NRF1, Proc Natl Acad Sci USA, 100, 8466, 10.1073/pnas.1032913100
Befroy, 2007, Impaired mitochondrial substrate oxidation in muscle of insulin-resistant offspring of type 2 diabetic patients, Diabetes, 56, 1376, 10.2337/db06-0783
Morino, 2005, Reduced mitochondrial density and increased IRS-1 serine phosphorylation in muscle of insulin-resistant offspring of type 2 diabetic parents, J Clin Invest, 115, 3587, 10.1172/JCI25151
Petersen, 2004, Impaired mitochondrial activity in the insulin-resistant offspring of patients with type 2 diabetes, N Engl J Med, 350, 664, 10.1056/NEJMoa031314
Gomez-Perez, 2008, Gender dimorphism in high-fat-diet-induced insulin resistance in skeletal muscle of aged rats, Cell Physiol Biochem, 22, 539, 10.1159/000185538
Mauvais-Jarvis, 2002, Knockout models are useful tools to dissect the pathophysiology and genetics of insulin resistance, Clin Endocrinol (Oxf), 57, 1, 10.1046/j.1365-2265.2002.01563.x
Tiwari-Woodruff, 2009, Neuroprotective and anti-inflammatory effects of estrogen receptor ligand treatment in mice, J Neurol Sci, 286, 81, 10.1016/j.jns.2009.04.023
Spence, 2012, 2011 Neuroprotective effects of estrogens and androgens in CNS inflammation and neurodegeneration, Front Neuroendocrinol, 33, 105, 10.1016/j.yfrne.2011.12.001
Gold, 2009, Estrogen treatment decreases matrix metalloproteinase (MMP)-9 in autoimmune demyelinating disease through estrogen receptor α (ERα), Lab Invest, 89, 1076, 10.1038/labinvest.2009.79
Atwater, 2002, Pregnancy hormones prevent diabetes and reduce lymphocytic infiltration of islets in the NOD mouse, Ann Clin Lab Sci, 32, 87
Dulos, 2010, Suppression of the inflammatory response in experimental arthritis is mediated via estrogen receptor α but not estrogen receptor β, Arthritis Res Ther, 12, R101, 10.1186/ar3032
Yang, 2010, Endogenous estrogen regulation of inflammatory arthritis and cytokine expression in male mice, predominantly via estrogen receptor α, Arthritis Rheum, 62, 1017, 10.1002/art.27330
Klein, 2008, Estrogen and progesterone affect responses to malaria infection in female C57BL/6 mice, Gend Med, 5, 423, 10.1016/j.genm.2008.10.001
Vegeto, 2010, Estrogen receptor-α as a drug target candidate for preventing lung inflammation, Endocrinology, 151, 174, 10.1210/en.2009-0876
Calippe, 2010, 17β-Estradiol promotes TLR4-triggered proinflammatory mediator production through direct estrogen receptor α signaling in macrophages in vivo, J Immunol, 185, 1169, 10.4049/jimmunol.0902383
Hepworth, 2010, The role of sex hormones in the development of Th2 immunity in a gender-biased model of Trichuris muris infection, Eur J Immunol, 40, 406, 10.1002/eji.200939589
Lezama-Davila, 2008, Role of phosphatidylinositol-3-kinase-γ (PI3Kγ)-mediated pathway in 17β-estradiol-induced killing of L. mexicana in macrophages from C57BL/6 mice, Immunol Cell Biol, 86, 539, 10.1038/icb.2008.39
Douin-Echinard, 2011, Estradiol administration controls eosinophilia through estrogen receptor-α activation during acute peritoneal inflammation, J Leukoc Biol, 90, 145, 10.1189/jlb.0210073
Olefsky, 2010, Macrophages, inflammation, and insulin resistance, Annu Rev Physiol, 72, 219, 10.1146/annurev-physiol-021909-135846
Chawla, 2011, Macrophage-mediated inflammation in metabolic disease, Nat Rev Immunol, 11, 738, 10.1038/nri3071
Ribas, 2011, Myeloid-specific estrogen receptor α deficiency impairs metabolic homeostasis and accelerates atherosclerotic lesion development, Proc Natl Acad Sci USA, 108, 16457, 10.1073/pnas.1104533108
Wong, 2010, Extranuclear estrogen receptor-α stimulates NeuroD1 binding to the insulin promoter and favors insulin synthesis, Proc Natl Acad Sci USA, 107, 13057, 10.1073/pnas.0914501107
Tiano, 2011, Estrogen receptor activation reduces lipid synthesis in pancreatic islets and prevents β cell failure in rodent models of type 2 diabetes, J Clin Invest, 121, 3331, 10.1172/JCI44564
Tiano, 2012, Selective estrogen receptor modulation in pancreatic β-cells and the prevention of type 2 diabetes, Islets, 4, 173, 10.4161/isl.19747
Tiano, 2012, Molecular mechanisms of estrogen receptors' suppression of lipogenesis in pancreatic β-cells, Endocrinology, 153, 2997, 10.1210/en.2011-1980
Alonso-Magdalena, 2008, Pancreatic insulin content regulation by the estrogen receptor ER α, PLoS One, 3, e2069, 10.1371/journal.pone.0002069
2012, The 2012 hormone therapy position statement of: The North American Menopause Society, Menopause, 19, 257, 10.1097/gme.0b013e31824b970a
Choe, 2007, Chronic activation of liver X receptor induces β-cell apoptosis through hyperactivation of lipogenesis: liver X receptor-mediated lipotoxicity in pancreatic β-cells, Diabetes, 56, 1534, 10.2337/db06-1059
Le May, 2006, Estrogens protect pancreatic β-cells from apoptosis and prevent insulin-deficient diabetes mellitus in mice, Proc Natl Acad Sci USA, 103, 9232, 10.1073/pnas.0602956103
Liu, 2009, Importance of extranuclear estrogen receptor-α and membrane G protein-coupled estrogen receptor in pancreatic islet survival, Diabetes, 58, 2292, 10.2337/db09-0257
Liu, 2009, Rapid, nongenomic estrogen actions protect pancreatic islet survival, Islets, 1, 273, 10.4161/isl.1.3.9781
Baquie, 2011, The liver receptor homolog-1 (LRH-1) is expressed in human islets and protects β-cells against stress-induced apoptosis, Hum Mol Genet, 20, 2823, 10.1093/hmg/ddr193
Soriano, 2009, Rapid regulation of K(ATP) channel activity by 17β-estradiol in pancreatic β-cells involves the estrogen receptor β and the atrial natriuretic peptide receptor, Mol Endocrinol, 23, 1973, 10.1210/me.2009-0287
Soriano, 2012, Rapid insulinotropic action of low doses of bisphenol-A on mouse and human islets of Langerhans: role of estrogen receptor β, PLoS One, 7, e31109, 10.1371/journal.pone.0031109
Tiano, 2012, Selective estrogen receptor modulation in pancreatic β-cells and the prevention of type 2 diabetes, Islets, 4, 173, 10.4161/isl.19747
Balhuizen, 2010, Activation of G protein-coupled receptor 30 modulates hormone secretion and counteracts cytokine-induced apoptosis in pancreatic islets of female mice, Mol Cell Endocrinol, 320, 16, 10.1016/j.mce.2010.01.030
Kumar, 2011, Insulinotropic and antidiabetic effects of 17β-estradiol and the GPR30 agonist G-1 on human pancreatic islets, Endocrinology, 152, 2568, 10.1210/en.2010-1361
Sharma, 2011, Mechanisms of estradiol-induced insulin secretion by the G protein-coupled estrogen receptor GPR30/GPER in pancreatic β-cells, Endocrinology, 152, 3030, 10.1210/en.2011-0091
Contreras, 2002, 17β-Estradiol protects isolated human pancreatic islets against proinflammatory cytokine-induced cell death: molecular mechanisms and islet functionality, Transplantation, 74, 1252, 10.1097/00007890-200211150-00010
Salonia, 2006, Sexual function and endocrine profile in fertile women with type 1 diabetes, Diabetes Care, 29, 312, 10.2337/diacare.29.02.06.dc05-1067
Liu, 2013, Oestrogens improve human pancreatic islet transplantation in a mouse model of insulin deficient diabetes, Diabetologia, 56, 370, 10.1007/s00125-012-2764-1
Finan, 2012, Targeted estrogen delivery reverses the metabolic syndrome, Nat Med, 18, 1847, 10.1038/nm.3009
Tiano, 2012, A glucagon-like peptide-1-estrogen fusion peptide shows enhanced efficacy in preventing insulin-deficient diabetes in mice, Endocr Rev, 33, OR21
Khor, 2008, Gender-specific expression and mechanism of regulation of estrogen sulfotransferase in adipose tissues of the mouse, Endocrinology, 149, 5440, 10.1210/en.2008-0271
Khor, 2010, Estrogen sulfotransferase regulates body fat and glucose homeostasis in female mice, Am J Physiol Endocrinol Metab, 299, E657, 10.1152/ajpendo.00707.2009
Ahima, 2011, Estrogen sulfotransferase is expressed in subcutaneous adipose tissue of obese humans in association with TNF-α and SOCS3, J Clin Endocrinol Metab, 96, E1153, 10.1210/jc.2010-2903
Leiter, 1994, Obesity-induced diabetes (diabesity) in C57BL/KsJ mice produces aberrant trans-regulation of sex steroid sulfotransferase genes, J Clin Invest, 93, 2007, 10.1172/JCI117194
Gao, 2012, Sex-specific effect of estrogen sulfotransferase on mouse models of type 2 diabetes, Diabetes, 61, 1543, 10.2337/db11-1152
Mauvais-Jarvis, 1990, Percutaneous absorption of steroids
Good, 1999, Comparison of Alora estradiol matrix transdermal delivery system with oral conjugated equine estrogen therapy in relieving menopausal symptoms. Alora Study Group, Climacteric, 2, 29, 10.3109/13697139909025560
Sitruk-Ware, 1980, Absorption of percutaneous oestradiol in postmenopausal women, Maturitas, 2, 207, 10.1016/0378-5122(80)90005-5
Elkik, 1982, Effects of percutaneous estradiol and conjugated estrogens on the level of plasma proteins and triglycerides in postmenopausal women, Am J Obstet Gynecol, 143, 888, 10.1016/0002-9378(82)90468-9
Chu, 2006, A comparison of oral and transdermal short-term estrogen therapy in postmenopausal women with metabolic syndrome, Fertil Steril, 86, 1669, 10.1016/j.fertnstert.2006.04.043
Chu, 2008, Metabolic syndrome in postmenopausal women: the influence of oral or transdermal estradiol on inflammation and coagulation markers, Am J Obstet Gynecol, 199, 526.e1, 10.1016/j.ajog.2008.04.033
Salpeter, 2006, Meta-analysis: effect of hormone-replacement therapy on components of the metabolic syndrome in postmenopausal women, Diabetes Obes Metab, 8, 538, 10.1111/j.1463-1326.2005.00545.x
Grodstein, 2000, A prospective, observational study of postmenopausal hormone therapy and primary prevention of cardiovascular disease, Ann Intern Med, 133, 933, 10.7326/0003-4819-133-12-200012190-00008
Salpeter, 2009, Bayesian meta-analysis of hormone therapy and mortality in younger postmenopausal women, Am J Med, 122, 1016, 10.1016/j.amjmed.2009.05.021
Hulley, 1998, Randomized trial of estrogen plus progestin for secondary prevention of coronary heart disease in postmenopausal women. Heart and Estrogen/progestin Replacement Study (HERS) Research Group, JAMA, 280, 605, 10.1001/jama.280.7.605
Grodstein, 2001, Postmenopausal hormone use and secondary prevention of coronary events in the Nurses' Health Study. A prospective, observational study, Ann Intern Med, 135, 1, 10.7326/0003-4819-135-1-200107030-00003
Anderson, 2004, Effects of conjugated equine estrogen in postmenopausal women with hysterectomy: the Women's Health Initiative randomized controlled trial, JAMA, 291, 1701, 10.1001/jama.291.14.1701
Ogawa, 1998, Tamoxifen-induced fatty liver in patients with breast cancer, Lancet, 351, 725, 10.1016/S0140-6736(05)78493-2
Coskun, 2002, Tamoxifen therapy and hepatic steatosis, Neoplasma, 49, 61
Nishino, 2003, Effects of tamoxifen on hepatic fat content and the development of hepatic steatosis in patients with breast cancer: high frequency of involvement and rapid reversal after completion of tamoxifen therapy, AJR Am J Roentgenol, 180, 129, 10.2214/ajr.180.1.1800129
Lelliott, 2005, Transcript and metabolite analysis of the effects of tamoxifen in rat liver reveals inhibition of fatty acid synthesis in the presence of hepatic steatosis, FASEB J, 19, 1108, 10.1096/fj.04-3196com
Gudbrandsen, 2006, Causes and prevention of tamoxifen-induced accumulation of triacylglycerol in rat liver, J Lipid Res, 47, 2223, 10.1194/jlr.M600148-JLR200
Cole, 2010, Tamoxifen induces triacylglycerol accumulation in the mouse liver by activation of fatty acid synthesis, Hepatology, 52, 1258, 10.1002/hep.23813
Lopez, 2006, Tamoxifen-induced anorexia is associated with fatty acid synthase inhibition in the ventromedial nucleus of the hypothalamus and accumulation of malonyl-CoA, Diabetes, 55, 1327, 10.2337/db05-1356
Lipscombe, 2012, Association between tamoxifen treatment and diabetes: a population-based study, Cancer, 118, 2615, 10.1002/cncr.26559
Ettinger, 1999, Reduction of vertebral fracture risk in postmenopausal women with osteoporosis treated with raloxifene: results from a 3-year randomized clinical trial. Multiple Outcomes of Raloxifene Evaluation (MORE) Investigators, JAMA, 282, 637, 10.1001/jama.282.7.637
Meli, 2004, Estrogen and raloxifene modulate leptin and its receptor in hypothalamus and adipose tissue from ovariectomized rats, Endocrinology, 145, 3115, 10.1210/en.2004-0129
Tommaselli, 2006, Serum leptin levels and body composition in postmenopausal women treated with tibolone and raloxifene, Menopause, 13, 660, 10.1097/01.gme.0000227335.27996.d8
Francucci, 2005, Effects of raloxifene on body fat distribution and lipid profile in healthy post-menopausal women, J Endocrinol Invest, 28, 623, 10.1007/BF03347261
Barrett-Connor, 2003, Post hoc analysis of data from the Multiple Outcomes of Raloxifene Evaluation (MORE) trial on the effects of three years of raloxifene treatment on glycemic control and cardiovascular disease risk factors in women with and without type 2 diabetes, Clin Ther, 25, 919, 10.1016/S0149-2918(03)80114-5
Jacobsen, 2010, Raloxifene and body composition and muscle strength in postmenopausal women: a randomized, double-blind, placebo-controlled trial, Eur J Endocrinol, 162, 371, 10.1530/EJE-09-0619
Andersson, 2002, Raloxifene does not affect insulin sensitivity or glycemic control in postmenopausal women with type 2 diabetes mellitus: a randomized clinical trial, J Clin Endocrinol Metab, 87, 122, 10.1210/jcem.87.1.8168
Nagamani, 2008, Effects of raloxifene on insulin sensitivity, β-cell function, and hepatic insulin extraction in normal postmenopausal women, Fertil Steril, 89, 614, 10.1016/j.fertnstert.2007.03.083
Carr, 2005, Effect of raloxifene on serum triglycerides in women with a history of hypertriglyceridemia while on oral estrogen therapy, Diabetes Care, 28, 1555, 10.2337/diacare.28.7.1555
Kharode, 2008, The pairing of a selective estrogen receptor modulator, bazedoxifene, with conjugated estrogens as a new paradigm for the treatment of menopausal symptoms and osteoporosis prevention, Endocrinology, 149, 6084, 10.1210/en.2008-0817
Komm, 2008, A new approach to menopausal therapy: the tissue selective estrogen complex, Reprod Sci, 15, 984, 10.1177/1933719108325759
Sullivan, 2012, Selective estrogen receptor modulator promotes weight loss in ovariectomized female rhesus monkeys (Macaca mulatta) by decreasing food intake and increasing activity, Am J Physiol Endocrinol Metab, 302, E759, 10.1152/ajpendo.00327.2011